Coronary Artery Bypass Graft Market

Home   /   Coronary Artery Bypass Graft Market

Published Date: June 2021 | Pages: 156 | Category: Pharma and Healthcare | Report Code: GRMI28194

Extract:

Based on this comprehensive report publis

hed by Gravitas Market Insights, the Coronary Artery Bypass Graft market is said to witness a significant growth during the forecast years between 2021 and 2028. Coronary artery bypass graft is the type of graft used in the surgery that is responsible for improving the flow of blood to the heart. These grafts are used for treating the people who are suffering from severe coronary heart disease (CHD) that is also known as coronary artery disease.

 

Report Scope in detail:

 

This latest report edition of Coronary Artery Bypass Graft market has been added to our huge database of detailed reports and this envisions to shape the future of all the related businesses. Our team of learned research analysts have studied in-depth and curated the report based on several aspects which include the overview of the market, driving forces, growth rate, market trends, market size, opportunities and challenges of the market; along with detailed competitive analysis on the regional as well as global level. The Coronary Artery Bypass Graft market research report renders a thorough analysis of the market on a global aspect and aims on several market segmentation. This report also provides deeper perception into the latest trends of the market and pinpoints crucial product developments of the industry. Furthermore, the report collects numerous factors that have accredited to the growth of the market in the recent years.

 

 

Market Dynamics:

 

  • Constant surge in the number of cases of cardiovascular disease coupled with changing lifestyle is one of the major growth driving factors of coronary artery bypass graft market
  • There is a constant surge in geriatric population which is boosting the coronary artery bypass graft surgeries and this is anticipated to promote the market in the forecast period
  • In the procedure segment, the triple bypass surgeries segment is anticipated to boom the industry in the forecast period, due to the increased cases of cardiovascular diseases like CHD, CAD, MI and/or strokes across the world
  • By product type, the off-pump CABG segment is anticipated to acquire more market share during the forecast period

 

Coronary Artery Bypass Graft Market Segmentation:

 

By Procedure

 

  • Single CABG Surgery
  • Double CABG Surgery
  • Triple CABG Surgery
  • Quadruple CABG Surgery

 

By End-User

 

  • Hospitals
  • Cardiology Clinics
  • Research Institutes
  • Other End-Users

 

By Type

 

  • Off-Pump
  • On-Pump
  • Minimally Invasive Direct CABG
  • Endoscopic Vein Harvesting
  • Others

 

Regional Coverage

 

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Korea
    • Australia
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

 

Competitive Analysis:

 

Eminent market players have been outlined in order to extract improved insights into the worldwide businesses. Our research reports offer all-inclusive information on various top most manufacturers that are operational across global regions. We provide company profiles which include detailed overview of the company, business information, business performance, crucial strategies implemented through the years.

 

Few of the Key Players Covered in Our Report:

 

  • Off-Pump
  • On-Pump
  • Minimally Invasive Direct CABG
  • Endoscopic Vein Harvesting
  • Others
  • DEXTERA SURGICAL INC.
  • EDWARDS LIFESCIENCES CORPORATION
  • GENESEE BIOMEDICAL
  • HANCOCK JAFFE LABORATORIES, INC.
  • MAQUET Holding B.V. & Co. KG.
  • Neograft Inc.
  • NOVADAQ Technologies Inc.
  • Sorin Group
  • Terumo Cardiovascular Systems Corporation
  • VasoPrep Surgical
  • Scion Medical Technologies, LLC.

 

 

Impact of COVID19:

 

The COVID19 pandemic crippled the global economy, it resulted in a worldwide lockdown and this has majorly impacted numerous industries. Our industry experts are working round-the-clock to identify, accumulate and in-time deliver market analysis due to the effect of unprecedented decisions in COVID-19 repercussions on many businesses. The full version of this report will comprise the overall impact of the pandemic, and predicted alteration on the future outlook of the industry, by taking into the account the economic, political, technological and social parameters.

This research study involves broad usage of both secondary and primary data sources. The research process involves the identification of numerous factors which affect the industry, comprising the market environment, government policy, historical data, present trends in the market, competitive landscape, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.



Market Estimation

Top-down and bottom-up approaches are used for validating the market size for companies, regional segments along with relevant market segmentations such as product type and application.
This report includes market estimations which are based on the marketed sale price of a product. Further breakdown of product segments, particular market share are formed based on the weightage assigned to every segment, which is derived of their usage rate and average price. The entire probable factors which effect the markets and influence them in a great way are included in this research report; and have been accounted for, studied in-depth and are confirmed through primary research. These are then studies to get the final qualitative and quantitative data. Any of the factors such as the outcome of inflation, economic downfall, and any kind of policy and regulatory alterations and/or other such factors are not accounted for in the market forecast. All of this data is amalgamated and included with thorough inputs and analysis from Gravitas Market Insights is curated in this report.



Along with the previously mentioned approaches, various data triangulation methods, in order to conduct market estimations and market forecasting for the complete market segments are detailed in this report. Key Companies present in the said market are also acknowledged via in-depth secondary research and primary research.

Section 1: Executive Summary


1.1. Coronary Artery Bypass Graft Market Industry 360° outline, Year 2016 – 2028
1.2. Business Model Trends
1.3. Growth Trends
1.4. End-User/Type Trends
1.5. Regional Trends

 

Section 2: Market Dynamics - Coronary Artery Bypass Graft Market Industry Insights


2.1. Growth Drivers
2.2. Opportunities
2.3. Industry challenges
2.4. SWOT Analysis
2.5. Porter’s Analysis
2.6. Worldwide Industry Landscape, Year 2016 – 2028
2.7. Industry Segmentation
2.8. Technology & Invention landscape
2.9. Regional Landscape

 

2.9.1. North America
2.9.2. Europe
2.9.3. Asia-Pacific
2.9.4. South America
2.9.5. Middle East & Africa

 

2.10. Competitive Environment

 

 

Section 3: Global Coronary Artery Bypass Graft Market, By End-User

 

3.1. Segmentation Analysis, By End-User, 2016-2028
3.2. Market Share Segmentation Analysis, By End-User, 2016-2028
3.3. Hospitals

 

3.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

3.4. Cardiology Clinics

 

3.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

3.5. Research Institutes

 

3.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

3.6. Other End-Users

 

3.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

 

Section 4: Global Coronary Artery Bypass Graft Market, By Procedure

 

4.1. Segmentation Analysis, By Procedure, 2016-2028
4.2. Market Share Segmentation Analysis, By Procedure, 2016-2028
4.3. Single CABG Surgery

 

4.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

4.4. Double CABG Surgery

 

4.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

4.5. Triple CABG Surgery

 

4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

4.6. Quadruple CABG Surgery

 

4.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

 

Section 5: Global Coronary Artery Bypass Graft Market, By Type

 

5.1. Segmentation Analysis, By Type, 2016-2028
5.2. Market Share Segmentation Analysis, By Type, 2016-2028
5.3. Off-Pump

 

5.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

5.4. On-Pump

 

5.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

5.5. Minimally Invasive Direct CABG

 

5.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

5.6. Endoscopic Vein Harvesting

 

5.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

5.7. Others

 

5.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

 

Section 6: Global Coronary Artery Bypass Graft Market, Regional Analysis

 

6.1. Global Coronary Artery Bypass Graft Market, Regional Analysis

 

6.2. North America, Country level Analysis

 

6.2.1. North America Coronary Artery Bypass Graft Market estimates and forecast with Growth rate analysis, By End-User, 2016 – 2028
6.2.2. North America Coronary Artery Bypass Graft Market estimates and forecast with Growth rate analysis, By Procedure, 2016 – 2028
6.2.3. North America Coronary Artery Bypass Graft Market estimates and forecast with Growth rate analysis, By Type, 2016 – 2028

 

6.2.4. United States

 

6.2.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.2.5. Canada

 

6.2.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.2.6. Mexico

 

6.2.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.3. Europe Country level Analysis

 

6.3.1. Europe Coronary Artery Bypass Graft Market estimates and forecast with Growth rate analysis, By End-User, 2016 – 2028
6.3.2. Europe Coronary Artery Bypass Graft Market estimates and forecast with Growth rate analysis, By Procedure, 2016 – 2028
6.3.3. Europe Coronary Artery Bypass Graft Market estimates and forecast with Growth rate analysis, By Type, 2016 – 2028

 

6.3.4. UK

 

6.3.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.3.5. Germany

 

6.3.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.3.6. France

 

6.3.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.3.7. Italy

 

6.3.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.3.8. Spain

 

6.3.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.3.9. Russia

 

6.3.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.3.10. Rest of Europe

 

6.3.10.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.4. Asia-Pacific Country level Analysis

 

6.4.1. Asia-Pacific Coronary Artery Bypass Graft Market estimates and forecast with Growth rate analysis, By End-User, 2016 – 2028
6.4.2. Asia-Pacific Coronary Artery Bypass Graft Market estimates and forecast with Growth rate analysis, By Procedure, 2016 – 2028
6.4.3. Asia-Pacific Coronary Artery Bypass Graft Market estimates and forecast with Growth rate analysis, By Type, 2016 – 2028

 

6.4.4. China

 

6.4.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.4.5. India

 

6.4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.4.6. Japan

 

6.4.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.4.7. Korea

 

6.4.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.4.8. Australia

 

6.4.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.4.9. Southeast Asia

 

6.4.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.4.10. Rest of Asia-Pacific

 

6.4.10.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.5. South America Country level Analysis

 

6.5.1. South America Coronary Artery Bypass Graft Market estimates and forecast with Growth rate analysis, By End-User, 2016 – 2028
6.5.2. South America Coronary Artery Bypass Graft Market estimates and forecast with Growth rate analysis, By Procedure, 2016 – 2028
6.5.3. South America Coronary Artery Bypass Graft Market estimates and forecast with Growth rate analysis, By Type, 2016 – 2028

 

6.5.4. Brazil

 

6.5.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.5.5. Argentina

 

6.5.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.5.6. Colombia

 

6.5.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.5.7. Rest of South America

 

6.5.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.6. Middle East & Africa Country level Analysis

 

6.6.1. MEA Coronary Artery Bypass Graft Market estimates and forecast with Growth rate analysis, By End-User, 2016 – 2028
6.6.2. MEA Coronary Artery Bypass Graft Market estimates and forecast with Growth rate analysis, By Procedure, 2016 – 2028
6.6.3. MEA Coronary Artery Bypass Graft Market estimates and forecast with Growth rate analysis, By Type, 2016 – 2028

 

6.6.4. GCC

 

6.6.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.6.5. South Africa

 

6.6.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

6.6.6. Rest of Middle East & Africa

 

6.6.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

 

Section 7: Company Profile - Coronary Artery Bypass Graft Market

 

7.1. DEXTERA SURGICAL INC.

 

7.1.1. Business Overview
7.1.2. Product & Service Offering
7.1.3. Overall Revenue
7.1.4. Strategic Outlook

 

7.2. EDWARDS LIFESCIENCES CORPORATION

 

7.2.1. Business Overview
7.2.2. Product & Service Offering
7.2.3. Overall Revenue
7.2.4. Strategic Outlook

 

7.3. GENESEE BIOMEDICAL

 

7.3.1. Business Overview
7.3.2. Product & Service Offering
7.3.3. Overall Revenue
7.3.4. Strategic Outlook

 

7.4. HANCOCK JAFFE LABORATORIES, INC.

 

7.4.1. Business Overview
7.4.2. Product & Service Offering
7.4.3. Overall Revenue
7.4.4. Strategic Outlook

 

7.5. MAQUET Holding B.V. & Co. KG.

 

7.5.1. Business Overview
7.5.2. Product & Service Offering
7.5.3. Overall Revenue
7.5.4. Strategic Outlook

 

7.6. Neograft Inc.

 

7.6.1. Business Overview
7.6.2. Product & Service Offering
7.6.3. Overall Revenue
7.6.4. Strategic Outlook

 

7.7. NOVADAQ Technologies Inc.

 

7.7.1. Business Overview
7.7.2. Product & Service Offering
7.7.3. Overall Revenue
7.7.4. Strategic Outlook

 

7.8. Sorin Group

 

7.8.1. Business Overview
7.8.2. Product & Service Offering
7.8.3. Overall Revenue
7.8.4. Strategic Outlook

 

7.9. Terumo Cardiovascular Systems Corporation

 

7.9.1. Business Overview
7.9.2. Product & Service Offering
7.9.3. Overall Revenue
7.9.4. Strategic Outlook

 

7.10. VasoPrep Surgical

 

7.10.1. Business Overview
7.10.2. Product & Service Offering
7.10.3. Overall Revenue
7.10.4. Strategic Outlook

 

7.11. Scion Medical Technologies, LLC.

 

7.11.1. Business Overview
7.11.2. Product & Service Offering
7.11.3. Overall Revenue
7.11.4. Strategic Outlook

 

*******

 

*Market size and forecast will be provided from 2016-2028, and forecast period would be 2021-2028

 

*Details on financial performance and strategic moves and developments may not be captured for unlisted companies

 

*List of companies profiled in this TOC is tentative and may change after detailed analysis